Skip to main content

Table 3 Comparison of three matched cohorts on their pre-index date categorical variables using McNemar's test for paired observations.

From: Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: a database study

 

LABA or LAMATx

(n = 523)

LABA and LAMA Tx

(n = 523)

LABA, LAMA, and ICS Tx

(n = 523)

Significant Pairwise tests*

Categorical Variables

n

(%)

n

(%)

n

(%)

 

Male

280

(53.5)

280

(53.5)

280

(53.5)

NONE

North

210

(40.2)

218

(41.7)

222

(42.4)

NONE

Northeast

52

(9.9)

50

(9.6)

49

(9.4)

NONE

South

189

(36.1)

189

(36.1)

189

(36.1)

NONE

West

71

(13.6)

65

(12.4)

61

(11.7)

NONE

Cardiovascular specialist

170

(32.5)

181

(34.6)

176

(33.7)

NONE

Internist

253

(48.4)

260

(49.7)

264

(50.5)

NONE

Neoplasms

128

(24.5)

146

(27.9)

149

(28.5)

NONE

Pneumonia

51

(9.8)

51

(9.8)

51

(9.8)

NONE

Hypertension

187

(35.8)

209

(40.0)

203

(38.8)

NONE

Heart failure

59

(11.3)

53

(10.1)

56

(10.7)

NONE

Diseases of the respiratory system

482

(92.2)

475

(90.8)

477

(91.2)

NONE

Diabetes

67

(12.8)

71

(13.6)

73

(14.0)

NONE

Ischemic heart disease

116

(22.2)

116

(22.2)

116

(22.2)

NONE

Pulmonary vascular disease

16

(3.1)

19

(3.6)

15

(2.9)

NONE

Stroke

40

(7.6)

45

(8.6)

37

(7.1)

NONE

Hospital visit (≥ 1)

89

(17.0)

81

(15.5)

68

(13.0)

NONE

ER visit (≥ 1)

148

(28.3)

142

(27.2)

129

(24.7)

NONE

ER visit leading to hospitalization (≥ 1)

62

(11.9)

53

(10.1)

55

(10.5)

NONE

Non-Medicare payer type**

156

(29.8)

146

(27.9)

161

(30.8)

NONE

  1. *Based on McNemar's tests for paired observations. Pairwise tests were conducted and results are listed using the following notation: M = LABA or LAMA, D = LABA and LAMA, T = LABA, LAMA, ICS, NONE = No sig dif. All variables were derived from the 12 month pre-index period.
  2. **An indicator variable for Medicare versus Non-Medicare plan type was used. The plan type of Non-Medicare included Comprehensive, HMO, POS, EPO, PPO, and CDHP.